Web-based tool cuts cancer symptom distress

Web-based tool cuts cancer symptom distress

(HealthDay)—A web-based, self-report assessment and educational intervention is beneficial for reducing symptom distress during cancer therapy, according to a study published online Dec. 16 in the Journal of Clinical Oncology.

Donna L. Berry, Ph.D., R.N., from the Dana-Farber Cancer Institute in Boston, and colleagues assessed a web-based self-report in a trial involving 752 ambulatory adult participants who were randomized to symptom/quality of life (SxQOL) screening (control) or screening, targeted education, communication coaching, and the ability to track SxQOL over time (intervention). The assessment was used before a new therapeutic regimen, at three to six weeks and six to eight weeks later, and at the end of therapy. Self-reported data were delivered to clinicians at each time point.

The researchers found that from baseline to the end of the study there was a significant difference between the study groups in the mean change score on the Symptoms Distress Scale-15 (SDS-15) (1.27 in the control group [higher distress] versus −0.04 in the intervention group [lower distress]). There was an estimated 1.21 reduction in SDS-15 score in the (P = 0.02). Significant predictors included baseline SDS-15 score and clinical service. In multivariable analyses there was an interaction suggested between age and study group (P = 0.06); the benefit of intervention was strongest in those aged older than 50 years in subgroup analysis (P = 0.002).

"Web-based self-care support and communication coaching added to SxQOL screening reduced symptom distress in a multicenter sample of participants with various diagnoses during and after active cancer treatment," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Screening tool does not cut distress in cancer patients

Sep 07, 2013

(HealthDay)—Distress monitoring and needs assessment using the Distress Thermometer and Problem List (DT&PL) does not appear to be cost-effective in improving mood states in cancer patients, according to ...

Dexamethasone beats placebo for cancer-related fatigue

Aug 01, 2013

(HealthDay)—For patients with advanced cancer, dexamethasone is better than placebo for reducing cancer-related fatigue (CRF), according to a study published online July 29 in the Journal of Clinical On ...

Intervention for NICU moms reduces their trauma, anxiety

Sep 05, 2013

(HealthDay)—An intervention aimed at reducing parental trauma and redefining the parental experience for those with very premature newborns is both feasible and cost-effective, according to a study published ...

Recommended for you

Bone loss drugs may help prevent endometrial cancer

2 hours ago

A new analysis suggests that women who use bisphosphonates—medications commonly used to treat osteoporosis and other bone conditions—have about half the risk of developing endometrial cancer as women who do not use the ...

Putting the brakes on cancer

Dec 19, 2014

A study led by the University of Dundee, in collaboration with researchers at our University, has uncovered an important role played by a tumour suppressor gene, helping scientists to better understand how ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.